Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|2|124-131

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.2, 2012-02, pp. : 124-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colorectal cancer in review: the role of the EGFR pathway

By Saif Muhammad W  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 357-369

Informa Healthcare

Access to resources Recommend Favorite

Cancer of the Heart: Epidemiology and Management of Primary Tumors and Metastases

By Sarjeant J.M.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 6, 2003-01 ,pp. : 407-421

Adis International

Access to resources Recommend Favorite

Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 68-79

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Inflammation in Cancer-Related-Fatigue: A Rationale for Mistletoe Therapy as Supportive Care in Colorectal Cancer Patients

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite